Combretastatin A4-β-Galactosyl Conjugates for Ovarian Cancer Prodrug Monotherapy

DOI: 10.1021/acsmedchemlett.6b00427

Keywords: Antitumor agent, prodrug monotherapy, ovarian cancer, tubulin polymerization inhibitor, β-galactosidase, combretastatin A4

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text